Reply to McDonald and colleagues: “Can endoscopic ultrasound-guided gastroenterostomy be used as first line modality for endoscopic management of malignant gastric outlet obstruction?”

10.1055/a-1339-1230We would like to thank Dr. McDonald and colleagues for their comments on our manuscript “Patency of endoscopic ultrasound-guided gastroenterostomy in the treatment of malignant gastric outlet obstruction” [1]. The authors raised several points, the first of which was regarding issues about the higher adverse event (AE) rate reported in our series compared with previous reports: 1) whether these rates were higher in earlier years; 2) whether AEs decreased over time; and 3) whether there was a substantial difference between the balloon-assisted technique and the direct technique.

Publikationsverlauf

Artikel online veröffentlicht:
19. Februar 2021

• References

• 1 Kastelijn JB, Moons LMG, Garcia-Alonso FJ. et al. Patency of endoscopic ultrasound-guided gastroenterostomy in the treatment of malignant gastric outlet obstruction. Endosc Int Open 2020; 8: E1194-E1201
• 2 Itoi T, Ishii K, Ikeuchi N. et al. Prospective evaluation of endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy bypass (EPASS) for malignant gastric outlet obstruction. Gut 2016; 65: 193-195
• 3 Jeurnink SM, Steyerberg EW, van Hooft JE. et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71: 490-499